The present work investigates the chemo-preventive properties of cucurbitacin D, a compound with a broad range of anticancer effects, in hematological cancer cells, specifically with regard to its ability to modulate ZNF217 expression. Here, ZNF217 is linked to hematopoietic and lymphoid cell neoplasm.